Worldwide Hemato Oncology Testing Demand Is Valued At US$ 4.33 Billion In 2023
Throughout the projection period, it is expected that demand for hemato-oncology testing services will increase at a CAGR of 17.5%. The prevalence of leukaemia, non-Hodgkin …